banner
Cysteine protease inhibitor E-64, Purity ≥98%
Inquiry

Cat. No.: X24-07-ZQ748

Cysteine protease inhibitor E-64, Purity ≥98%

Synonym: 66701-25-5; Cysteine protease inhibitor; E64; E 64

  • MDL: MFCD00080261
  • CAS Number: 66701-25-5
  • Compound CID: 123985
img
Product Size
25 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
E-64, soluble in warmed DMSO and warmed water and insoluble in ethanol, obstructs cysteine proteases, enzymes implicated in numerous diseases due to their role in protein degradation. It targets Cysteine protease.
Molecular Weight
357.41
Molecular Formula
C15H27N5O5
Targets
Cysteine protease: 9 nM
Form
Lyophilized powder
Purity
≥98%
Solubility
Warmed DMSO: 61 mg/mL (170.67 mM); Warmed water: 9 mg/mL (25.18 mM); Ethanol: Insoluble
Identity
Confirmed by NMR/HPLC/MS.
Applications
E-64 is a cysteine protease inhibitor used to study and inhibit proteases like cathepsins, facilitating research in degenerative diseases and cancer.
Publications
Publications (0)

Publications

×
Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.

  • You can upload up to 5 images or ZIP files, and the size of a single file may not exceed 5MB.
Related Products
Quick Links

About Us

CD BioGlyco is a leading biotechnology company specializing in glycobiology. We deliver high-quality products and services to support cutting-edge research worldwide.

Contact Us

  • For research and manufacturing partners only. Not intended for (direct) human or veterinary use.
Copyright © CD BioGlyco. All rights reserved.